232 related articles for article (PubMed ID: 9412570)
1. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
Tinkle SS; Newman LS
Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
[TBL] [Abstract][Full Text] [Related]
2. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
[TBL] [Abstract][Full Text] [Related]
3. Beryllium induces IL-2 and IFN-gamma in berylliosis.
Tinkle SS; Kittle LA; Schumacher BA; Newman LS
J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
[TBL] [Abstract][Full Text] [Related]
4. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
5. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
6. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
[TBL] [Abstract][Full Text] [Related]
7. Beryllium induces apoptosis in human lung macrophages.
Kittle LA; Sawyer RT; Fadok VA; Maier LA; Newman LS
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):101-13. PubMed ID: 12102605
[TBL] [Abstract][Full Text] [Related]
8. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
9. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
10. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
Tinkle SS; Kittle LA; Newman LS
J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
[TBL] [Abstract][Full Text] [Related]
11. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
12. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.
Maier LA; Sawyer RT; Bauer RA; Kittle LA; Lympany P; McGrath D; Dubois R; Daniloff E; Rose CS; Newman LS
Am J Respir Crit Care Med; 2001 Oct; 164(7):1192-9. PubMed ID: 11673208
[TBL] [Abstract][Full Text] [Related]
13. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
[TBL] [Abstract][Full Text] [Related]
14. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.
Inoue Y; Barker E; Daniloff E; Kohno N; Hiwada K; Newman LS
Am J Respir Crit Care Med; 1997 Jul; 156(1):109-15. PubMed ID: 9230733
[TBL] [Abstract][Full Text] [Related]
16. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.
Jablonska E
Cytokine; 1998 Jul; 10(7):540-3. PubMed ID: 9702418
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
Girardin E; Roux-Lombard P; Grau GE; Suter P; Gallati H; Dayer JM
Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
[TBL] [Abstract][Full Text] [Related]
20. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]